Inicio>>Signaling Pathways>> Neuroscience>> Histamine Receptor>>Diphenhydramine HCl

Diphenhydramine HCl (Synonyms: DPH)

Catalog No.GC10445

La difenhidramina HCl es un antagonista del receptor H1 de histamina de primera generaciÓn con efecto anticolinérgico.

Products are for research use only. Not for human use. We do not sell to patients.

Diphenhydramine HCl Chemical Structure

Cas No.: 147-24-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
36,00 $
Disponible
50mg
50,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Diphenhydramine hydrochloride, a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations.Target: Histamine H1 receptorDiphenhydramine hydrochloride, a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Diphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.

References:
[1]. Benadryl. From Wikipedia, the free encyclopedia

Reseñas

Review for Diphenhydramine HCl

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Diphenhydramine HCl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.